ADVB
Advanced Biomed·NASDAQ
--
--(--)
--
--(--)
6.67 / 10
Outperform
Fund flow dynamics are the lone bright spot, scoring 6.67/10 and classified as 'good'. Ratios such as Small-inflow (0.4558) and Medium-inflow (0.4719) suggest net money inflows despite a negative overall trend flag. There is no analyst coverage to complement this data, so the current positive fund flow is critical to monitor for sustainability.
Fund Flow Rating
What is the analyst consensus for ADVB?
- ADVB holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.67/10 (Outperform).
